Pathogenesis of HIV-associated heart disease.

Giuseppe Barbaro

Journal: AIDS (London, England) 2003;17 Suppl 1():S12-20

PMID: 12870526

Full Text on Ovid Technologies, Inc. View on PubMed

Abstract

As longevity increases in HIV-infected individuals after the introduction of highly active antiretroviral therapy regimens, long-term effects such as cardiovascular disease and, more specifically, symptomatic heart failure are emerging as leading health issues. In the present review article, we discuss HIV-associated cardiovascular disease, focusing on etiopathogenetic mechanisms that may play a role in diagnosis, management, and therapy of HIV-associated heart failure in the highly active antiretroviral therapy era.

Address: Department of Medical Pathophysiology, University La Sapienza, Rome, Italy. [email protected]

DOI: 10.1097/00002030-200304001-00003

Link outs

Free resources

Medical:

https://medlineplus.gov/hivmedicines.html

Research Materials:

https://antibodies.cancer.gov/detail/CPTC-HLA-B-1

Subscription / membership required

Full Text Sources:

MeSH Terms: Antiretroviral Therapy, Highly Active, Cardiomyopathy, Dilated, Cardiovascular Diseases, Coronary Disease, Endothelium, Vascular, HIV Infections, Heart Neoplasms, Humans, Hypertension, Nutrition Disorders, Pericardial Effusion, Ventricular Dysfunction, Right